Clinical and Immunological Correction of DOCK8 Deficiency by Allogeneic Hematopoietic Stem Cell Transplantation Following a Reduced Toxicity Conditioning Regimen

By Boztug Heidrun   Karitnig-Weiß Cäcilia   Ausserer Bernd   Renner Ellen D.   Albert Michael H.   Sawalle-Belohradsky Julie   Belohradsky Bernd H.   Mann Georg   Horcher Ernst   Rümmele-Waibel Alexandra   Geyeregger Rene   Lakatos Karoly   Peters Christina   Lawitschka Anita   Matthes-Martin Susanne  

Pediatric Hematology and Oncology, Vol. 29, Iss. 7, 2012-09 ,pp. : 585-594

Informa Healthcare

Access to resources Recommend Favorite

Factors Influencing Outcome and Incidence of Late Complications in Children who Underwent Allogeneic Hematopoietic Stem Cell Transplantation for Hemoglobinopathy

By Khalil Abdalla   Zaidman Irena   Elhasid Ronit   Peretz-Nahum Monique   Futerman Boris   Ben-Arush Myriam  

Pediatric Hematology and Oncology, Vol. 29, Iss. 8, 2012-10 ,pp. : 694-703

Informa Healthcare

Access to resources Recommend Favorite

Response to the Letter: Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease

By Ito Sawa   Barrett A. John  

Pediatric Hematology and Oncology, Vol. 30, Iss. 5, 2013-08 ,pp. : 462-463

Informa Healthcare

Access to resources Recommend Favorite

Allogeneic Hematopoietic Stem Cell Transplantation for Treatment of Gaucher Disease

By Machaczka Maciej  

Pediatric Hematology and Oncology, Vol. 30, Iss. 5, 2013-08 ,pp. : 459-461

Informa Healthcare

Access to resources Recommend Favorite

Significant Morbidity and Mortality Attributable to Rothia Mucilaginosa Infections in Children with Hematological Malignancies or Following Hematopoietic Stem Cell Transplantation

By Chavan Rishikesh S.  

Pediatric Hematology and Oncology, Vol. 30, Iss. 5, 2013-08 ,pp. : 445-454

Informa Healthcare

Access to resources Recommend Favorite